Title
Category
Credits
Event date
Cost
- Opioid Use Disorder (OUD)
- Pharmacology
- 10.00 AMA PRA Category 1 Credit™
- 10.00 ANCC
- 10.00 ASWB
$70.00
Morphine and heroin were first synthesized and used medicinally in the nineteenth century, and recreational and illicit use followed. Historically, heroin dependence has been difficult to treat successfully, with poor outcome being attributed to patient characteristics, environmental factors, and the powerful reinforcing effects of the drug. Agonist-replacement therapy was introduced more than 40 years ago and represented a breakthrough in the management of heroin addiction.
- Palliative Care
- Buprenorphine
- Opioid Use Disorder (OUD)
- Pain Management
- 1.00 AMA PRA Category 1 Credit™
$0.00
In this recorded Palliative Care Educational Series presentation, palliative care and addiction medicine specialist Dr. Janet Ho provides a comprehensive overview on the use of buprenorphine, a partial opioid agonist, for pain management and treatment of opioid use disorder. Dr. Ho begins with an overview of buprenorphine's pharmacology, including its unique properties as a partial agonist with a strong binding affinity to the mu-opioid receptor, its ceiling effect on respiratory depression, and its ability to reduce hyperalgesia and cravings. Dr.
- Opioid Use Disorder (OUD)
- 1.50 AMA PRA Category 1 Credit™
$0.00
The "Opioid Addiction Identification and Medication for Opioid Use Disorder (MOUD)" course is an educational program designed to equip healthcare professionals with the knowledge and skills necessary to effectively address the opioid crisis. Led by an expert in addiction medicine, participants will explore key topics such as the definition and scope of opioid addiction, the neurobiology of addiction, risk factors for opioid addiction, and common signs and symptoms of opioid use disorder.
- Opioid Use Disorder (OUD)
- Pain Management
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
$0.00
Learn how to apply the 2022 Clinical Practice Guideline to effectively manage patients in the emergency department setting who present with pain or opioid-related adverse events, such as overdose or opioid use disorder (OUD).WB4713
- Buprenorphine
- Opioid Use Disorder (OUD)
- 0.50 AMA PRA Category 1 Credit™
$0.00
The X-Waiver is gone! This educational activity will show you how to incorporate buprenorphine prescribing for opioid use disorder into your clinical practice.Rhode Island Specific: This course qualifies for 0.5 hours of risk management credit.
- Opioid Use Disorder (OUD)
- 1.00 AMA PRA Category 1 Credit™
- 1.00 AOA Category 1-A
$0.00
This lecture is designed to address:Evidence that treatment worksConsequences of InactionOvercoming barriers to evidence based care Research Testing Innovative Solutions
- Buprenorphine
- Opioid Use Disorder (OUD)
- 1.00 AMA PRA Category 1 Credit™
- 1.00 AOA Category 1-A
$0.00
This talk will describe the distribution of buprenorphine patient caseloads for clinicians prescribing formulations of buprenorphine indicated to treat opioid use disorder, how those caseloads evolve over time, and factors associated higher-volume buprenorphine prescribers. The presentation will also discuss implications for expanding access to medication treatment for opioid use disorder and state and federal policy efforts.
- Depression
- Opioid Use Disorder (OUD)
- Suicide
- 1.00 AMA PRA Category 1 Credit™
- 1.00 AOA Category 1-A
$0.00
This lecture will review the prevalence and challenges in managing patients with co-occurring opioid use disorder, depression and self-injurious behavior.
- Opioid Use Disorder (OUD)
- 1.00 AMA PRA Category 1 Credit™
- 1.00 AOA Category 1-A
$0.00
This lecture will review current data on opioid use in youth. Treatment strategies including medication management, behavioral interventions, and harm reduction approaches will be discussed.